Psoriasis and comorbid diseases: epidemiology

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being
recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known …

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

CA Elmets, CL Leonardi, DMR Davis… - Journal of the American …, 2019 - Elsevier
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with
awareness and attention to comorbidities - ScienceDirect Skip to main contentSkip to article …

HDL in the 21st century: a multifunctional roadmap for future HDL research

A Rohatgi, M Westerterp, A Von Eckardstein… - Circulation, 2021 - Am Heart Assoc
Low high-density lipoprotein cholesterol (HDL-C) characterizes an atherogenic dyslipidemia
that reflects adverse lifestyle choices, impaired metabolism, and increased cardiovascular …

Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study

YA Elnabawi, AK Dey, A Goyal… - Cardiovascular …, 2019 - academic.oup.com
Aims The use of biologic therapy has increased over the past decade well beyond primary
autoimmune diseases. Indeed, a recent trial using an anti-IL-1beta antibody reduced second …

Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment

SCS Hu, CCE Lan - International journal of molecular sciences, 2017 - mdpi.com
Psoriasis is a common and chronic inflammatory disease of the skin. It may impair the
physical and psychosocial function of patients and lead to decreased quality of life …

Psoriasis and comorbid diseases: Implications for management

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
As summarized in the first article in this continuing medical education series, the currently
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …

[HTML][HTML] Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus

PM Carlucci, MM Purmalek, AK Dey… - JCI insight, 2018 - ncbi.nlm.nih.gov
BACKGROUND. Systemic lupus erythematosus (SLE) is associated with enhanced risk of
atherosclerotic cardiovascular disease not explained by Framingham risk score (FRS) …

A phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U trial)

JM Gelfand, DB Shin, A Alavi, DA Torigian… - Journal of Investigative …, 2020 - Elsevier
Psoriasis is a T helper type 17 autoimmune disease associated with an increased risk
cardiovascular events and mortality. Ustekinumab, an antibody to p40, blocks cytokines IL …

Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study

JB Lerman, AA Joshi, A Chaturvedi, TM Aberra… - Circulation, 2017 - Am Heart Assoc
Background: Psoriasis, a chronic inflammatory disease associated with an accelerated risk
of myocardial infarction, provides an ideal human model to study inflammatory …

Lipid abnormalities and inflammation in HIV inflection

NT Funderburg, NN Mehta - Current HIV/AIDS Reports, 2016 - Springer
Infection with the human immunodeficiency virus (HIV), and subsequent treatment with
antiretroviral therapy (ART), is often associated with perturbations in lipid profiles …